Pathology Doctors in St Louis, MO Accepting Medicare

8 Pathology doctors found. Showing 1 - 8

Nancy J Phillips, MD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 1402 S Grand, St Louis, MO 63110 Phone: 314-577-8693    Fax: 314-268-5478

William Henry Boyce, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 525 Couch Ave, St Louis, MO 63122 Phone: 314-721-1531    Fax: 314-822-6316

Stephen E Godfrey, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10010 Kennerly Road, St Louis, MO 63128 Phone: 314-525-4345    Fax: 314-525-4354

Edward Stephen Bolesta, MD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 1402 S Grand, St Louis, MO 63104 Phone: 314-577-8000

Richard G Hoover, MD Pathology - Immunopathology Medicare: Not Enrolled in Medicare Practice Location: 1402 S Grand, St Louis, MO 63110 Phone: 314-577-8693    Fax: 314-268-5478

Leonard E Grosso, MD PHD Pathology - Immunopathology Medicare: Not Enrolled in Medicare Practice Location: 1402 S Grand, St Louis, MO 63110 Phone: 314-577-8693    Fax: 314-268-5478

Michael A Graham, Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 1402 S Grand, St Louis, MO 63110 Phone: 314-577-8693    Fax: 314-268-5478

Christine M Janney, MD Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 1402 S Grand, St Louis, MO 63110 Phone: 314-577-8693    Fax: 314-268-5478

News Archive

BioTime enters MTA with UC to make research-grade hES cell lines

BioTime, Inc. today announced a material transfer agreement (MTA) with the University of California (UC) system to make five research-grade human embryonic stem (hES) cell lines available to UC system researchers. These lines are genetically identical to a bank of GMP-compliant hES cell lines that will be made available to California-based researchers under a recent agreement between BioTime and the California Institute for Regenerative Medicine (CIRM).

HMS Holdings reports third quarter 2013 financial and operating results

HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report its third quarter 2013 financial and operating results at 8:00 a.m. Central/9:00 a.m. Eastern on Friday, November 8, 2013. Supplemental financial information including the press release and presentation will be available at http://investor.hms.com/events.cfm at approximately 7:30 a.m. Eastern on November 8.

Mobetron portable radiation therapy system for breast cancer treatment

One minute of radiation in the operating room (OR) could save the lives of thousands of women being treated for breast cancer in the US today. According to a growing body of research, a 60-second course of radiation therapy delivered during surgery dramatically improves results. But, until recently, logistical and administrative difficulties prevented most patients from receiving this crucial treatment until weeks after their procedures.

Colorado PERA now offers new hip and knee replacement benefit option for retirees in pre-Medicare program

Taking a critical step in eliminating confusion around health care costs, as well as addressing a significant need among today's retired workers, Colorado Public Employees' Retirement Association announced it will now offer its retirees in the pre-Medicare program a new hip and knee replacement benefit option called PERACare Select.

Read more Medical News

› Verified 5 days ago